4//SEC Filing
Lachey Jennifer 4
Accession 0001209191-22-036800
CIK 0001664710other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 6:57 PM ET
Size
7.0 KB
Accession
0001209191-22-036800
Insider Transaction Report
Form 4
Lachey Jennifer
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2022-06-14$0.30/sh+9,400$2,820→ 95,100 total - Exercise/Conversion
Employee Stock Option (right to buy)
2022-06-14−9,400→ 56,705 totalExercise: $0.30Exp: 2028-03-25→ Common Stock (9,400 underlying)
Footnotes (1)
- [F1]Immediately exercisable.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001808322
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 6:57 PM ET
- Size
- 7.0 KB